Kathryn Mills to Cystadenocarcinoma, Serous
This is a "connection" page, showing publications Kathryn Mills has written about Cystadenocarcinoma, Serous.
Connection Strength
0.298
-
SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth. Gynecol Oncol. 2018 11; 151(2):337-344.
Score: 0.163
-
Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy. PLoS One. 2016; 11(1):e0147145.
Score: 0.136